Sandra Gurrola, Senior Vice President of Finance, resigned from Ernexa Therapeutics Inc. effective July 3, 2026. She will provide part-time transition assistance for up to 10 hours per week until the filing of the Q2 2026 Form 10-Q. Ernexa Therapeutics Inc. is a biotechnology company focused on developing therapeutic solutions.
